No announcement yet.

Fluzone High-Dose Seasonal Flu Vaccine for Seniors Approved

  • Filter
  • Time
  • Show
Clear All
new posts

  • Fluzone High-Dose Seasonal Flu Vaccine for Seniors Approved

    Flu Vaccine for Seniors Approved
    A high-dose shot for people 65 and older

    THURSDAY, Dec. 24 (HealthDay News) -- Fluzone High-Dose, a seasonal flu vaccine for people 65 and older, has been approved by the U.S. Food and Drug Administration, the agency said in a news release.

    Seniors are at highest risk for complications of seasonal flu, including hospitalization and death. The Fluzone High-Dose vaccine, designed to prevent infection with influenza subtypes A and B, was given accelerated approval as a product designed to prevent serious or life-threatening disease. As part of the approval, manufacturer Sanofi Pasteur is required to "conduct further studies to verify that [the vaccine] will decrease seasonal influenza after vaccination," the FDA said.

    Because of the vaccine's higher potency, mild side effects were reported more frequently compared with Sanofi's standard-strength Fluzone vaccine, the agency said. These included pain, injection-site redness and swelling, headache, muscle ache and fever.
    People who are sensitive to egg products or who have had life-threatening
    reactions to prior flu shots shouldn't be vaccinated with Fluzone High-Dose, the FDA said.

    More information

    The U.S. Centers for Disease Control and Prevention has more about flu vaccination.

    "Safety and security don't just happen, they are the result of collective consensus and public investment. We owe our children, the most vulnerable citizens in our society, a life free of violence and fear."
    -Nelson Mandela